WO2007099460A2 - Electrosurgical methods and devices employing phase-controlled radiofrequency energy - Google Patents
Electrosurgical methods and devices employing phase-controlled radiofrequency energy Download PDFInfo
- Publication number
- WO2007099460A2 WO2007099460A2 PCT/IB2007/001585 IB2007001585W WO2007099460A2 WO 2007099460 A2 WO2007099460 A2 WO 2007099460A2 IB 2007001585 W IB2007001585 W IB 2007001585W WO 2007099460 A2 WO2007099460 A2 WO 2007099460A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tissue
- electrosurgical
- electrodes
- target site
- skin
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 99
- 239000000523 sample Substances 0.000 claims abstract description 68
- 238000011282 treatment Methods 0.000 claims abstract description 58
- 210000001519 tissue Anatomy 0.000 claims description 122
- 210000003491 skin Anatomy 0.000 claims description 78
- 230000006378 damage Effects 0.000 claims description 68
- 210000004209 hair Anatomy 0.000 claims description 34
- 230000005684 electric field Effects 0.000 claims description 27
- 210000002615 epidermis Anatomy 0.000 claims description 16
- 210000000434 stratum corneum Anatomy 0.000 claims description 15
- 230000000694 effects Effects 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 11
- 230000017074 necrotic cell death Effects 0.000 claims description 11
- 238000002604 ultrasonography Methods 0.000 claims description 11
- 230000003902 lesion Effects 0.000 claims description 10
- 210000004207 dermis Anatomy 0.000 claims description 9
- 230000037303 wrinkles Effects 0.000 claims description 9
- 208000012641 Pigmentation disease Diseases 0.000 claims description 7
- 206010000496 acne Diseases 0.000 claims description 7
- 210000003780 hair follicle Anatomy 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 230000019612 pigmentation Effects 0.000 claims description 7
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 6
- 230000004044 response Effects 0.000 claims description 6
- 208000035484 Cellulite Diseases 0.000 claims description 5
- 206010049752 Peau d'orange Diseases 0.000 claims description 5
- 230000036232 cellulite Effects 0.000 claims description 5
- 208000032544 Cicatrix Diseases 0.000 claims description 4
- 201000004681 Psoriasis Diseases 0.000 claims description 4
- 231100000241 scar Toxicity 0.000 claims description 4
- 230000037387 scars Effects 0.000 claims description 4
- 238000002054 transplantation Methods 0.000 claims description 4
- 206010008570 Chloasma Diseases 0.000 claims description 3
- 208000003351 Melanosis Diseases 0.000 claims description 3
- 206010040943 Skin Ulcer Diseases 0.000 claims description 3
- 230000003444 anaesthetic effect Effects 0.000 claims description 3
- 230000003716 rejuvenation Effects 0.000 claims description 3
- 230000000699 topical effect Effects 0.000 claims description 3
- 231100000216 vascular lesion Toxicity 0.000 claims description 3
- 210000004204 blood vessel Anatomy 0.000 claims description 2
- 210000004919 hair shaft Anatomy 0.000 claims description 2
- 206010024217 lentigo Diseases 0.000 claims description 2
- 210000004400 mucous membrane Anatomy 0.000 claims description 2
- 210000000056 organ Anatomy 0.000 claims description 2
- 230000001276 controlling effect Effects 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 230000001105 regulatory effect Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 abstract description 2
- 238000001816 cooling Methods 0.000 description 18
- 230000009759 skin aging Effects 0.000 description 9
- 230000003287 optical effect Effects 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 239000004677 Nylon Substances 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 229920001778 nylon Polymers 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 239000004065 semiconductor Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 230000035876 healing Effects 0.000 description 3
- 208000000069 hyperpigmentation Diseases 0.000 description 3
- 230000003810 hyperpigmentation Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000003367 Hypopigmentation Diseases 0.000 description 2
- 206010039580 Scar Diseases 0.000 description 2
- 238000002679 ablation Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000003574 free electron Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000003425 hypopigmentation Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010034203 Pectus Carinatum Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000037369 collagen remodeling Effects 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- -1 moles Chemical compound 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000009117 preventive therapy Methods 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000005067 remediation Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000013334 tissue model Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/203—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
- A61B2018/00476—Hair follicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00702—Power or energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/0075—Phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00869—Phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00875—Resistance or impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00994—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combining two or more different kinds of non-mechanical energy or combining one or more non-mechanical energies with ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1273—Generators therefor including multiple generators in one device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1467—Probes or electrodes therefor using more than two electrodes on a single probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0008—Destruction of fat cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
Definitions
- This disclosure relates generally to electrosurgical methods and devices.
- the methods and devices disclosed herein find utility, for example, in the field of medicine.
- Radiofrequency (RF) devices are used to non-specifically and non-selectively ablate or heat different types of tissue.
- RF devices are used to treat aging skin.
- Skin aging is associated with changes in the upper levels of the skin such as roughness of the skin due to changes in the stratum corneum and epidermis and uneven pigmentation in the epidermis.
- aging and environmental factors cause the destruction and malfunction of collagen and elastin fibers leading to the formation of wrinkles.
- Symptoms of skin aging in the epidermis are typically treated by ablative methods such as chemical peels or laser resurfacing.
- Optical radiation devices such as lasers are used to resurface large areas of the skin. While these lasers are effective in the treatment of the signs of skin aging, resurfacing the whole epidermis is often associated with side effects such as wound infections, prolonged healing times, hyperpigmentation, hypopigmentation, and scarring.
- WO 05/007003 describes a method for achieving beneficial effects in a target tissue in skin comprising treating the target tissue using optical radiation to create a plurality of microscopic treatment zones in a predetermined treatment pattern.
- This method of resurfacing the skin necessitates the use of complicated and expensive laser devices and requires special facilities, prolonged treatment times, and highly trained operators.
- Radiofrequency (RF) devices are used to ablate localized skin lesions or to destroy the whole upper surface of the skin.
- whole skin resurfacing methods and devices cause burn like post treatment reactions associated with prolonged healing times, increased risk of infections, prolonged erythema, scarring, hyperpigmentation, and hypopigmentation.
- US 6,711 ,435 discloses a device for ablating the stratum corneum epidermis of a subject, including a plurality of electrodes, which are applied to the subject's skin at respective points.
- this device does not ablate the epidermis and thus has no effects on the signs of skin aging.
- active and return electrodes that are typically positioned relatively close to one another at the treatment site. In some cases, the two electrodes are located on the same electrosurgical probe, and the electrodes alternate between functioning as active and return electrodes.
- Other RF devices use unipolar or monopolar electrical energy for heating the deep layers of skin. These devices also use an active electrode and a return electrode. The return electrode is typically positioned a relatively large distance from the active electrode (in comparison with bipolar devices). For both unipolar and bipolar devices, current flows along the lowest impedance path between electrodes.
- the devices described previously lack the ability to control the spatial directions, energies, and nature of the electrical energies affecting the treated area and thus lack the selectivity and specificity needed for maximum efficacy in their respective therapeutic indications.
- the bipolar and monopolar RF devices lack the ability to treat the signs of aging in the epidermis. Enhanced ability to control the spatial directions and the pattern of electron flows in the treated biological tissue would allow effective therapy for additional dermatological and non-dermatological disorders such as hair removal, acne, acne scars, psoriasis, bone grafting and more.
- the present disclosure is directed at addressing one or more of the abovementioned drawbacks of known electrosurgical methods and devices.
- the disclosure describes a method for delivering energy to a target site of a patient. The method comprises placing an electrosurgical probe into close proximity of the target site and delivering phase controlled RF energy to the electrosurgical probe.
- the disclosure describes a method for modifying living tissue.
- the method comprises exposing the tissue to an electric field, wherein the electric field is generated by an electrosurgical device.
- the electrosurgical device comprises an electrosurgical probe comprising a plurality of electrodes electrically coupled to: (i) first and second RF sources; or (ii) an RF source comprising first and second RF outputs.
- the electrosurgical probe further comprises means for controlling the phase between the RF energy supplied to the plurality of electrodes.
- the disclosure describes an electrosurgical system.
- the electrosurgical system comprises a means for applying RF energy to a target site of a patient.
- the electrosurgical system further comprises a generator comprising: (i) first and second RF power sources or an RF power source comprising first and second RF outputs; and (ii) a means for controlling the phase between the first and second RF power sources.
- a generator comprising: (i) first and second RF power sources or an RF power source comprising first and second RF outputs; and (ii) a means for controlling the phase between the first and second RF power sources.
- the disclosure describes a method for treating living tissue.
- the method comprises applying an electric field to a surface of the tissue by means of the electrosurgical system as described herein.
- the electrical energy causes tissue necrosis within a region of the tissue, the width of the region being confined to a substantially circular area of the tissue surface having a diameter in the range of about 1 ⁇ m to about 4000 ⁇ m.
- the disclosure describes a method for causing tissue necrosis.
- the method comprises contacting a surface of the tissue with two or more electrodes and applying an electrical potential between the electrodes. Necrosis occurs in the area between the two electrodes and is confined to a region that has a diameter in the range of about 1 ⁇ m to about 4000 ⁇ m.
- Figures Ia and Ib are example illustrations of the electrosurgical devices as disclosed herein.
- Figures 2a, 2b, 2c, and 2d are example illustration of electrosurgical probes as described herein.
- Figure 3 is an example illustration of focal damage regions as formed by the methods and devices disclosed herein.
- Figure 4 is an example illustration of focal damage regions that are located entirely below the surface of the tissue at the treatment site.
- Figure 5 is an example illustration of focal damage regions that begin at and extend .below the surface of the treated tissue.
- Figure 6 is an example illustration of the application of phase controlled RF energy to skin surrounding a hair follicle.
- Figure 7 is an example illustration of the application of energy in the form of phased RF and light energy to skin tissue surrounding a hair follicle.
- Figure 8 is a representation of skin tissue showing the effect of combining phased RF energy with optical photoselective light energy.
- Figures 9a, 9b 5 and 9c depict examples of electrosurgical devices as described herein.
- FIG. 10 is a graph showing two RF signals having different phases as well as the signal that results from their summation.
- Figure 11 shows a circuit diagram for a typical Class D type RF generator.
- Figure 12 shows graphs of output power versus input voltage for an RF generator unit.
- Figure 13 is an example illustration of an electrosurgical device incorporating ultrasonic energy.
- an “electrosurgical device” refers to an electrosurgical system that may comprise components such as electrosurgical probes, power sources, connecting cables, and other components.
- treating refers to reduction in severity and/or frequency of symptoms, elimination of symptoms and/or underlying cause, prevention of the occurrence of symptoms and/or their underlying cause (e.g., prophylactic therapy), and improvement or remediation of damage.
- patient or “subject” is meant any animal for which treatment is desirable. Patients may be mammals, and typically, as used herein, a patient is a human individual.
- light and light energy as used herein are meant to include visible, infrared, and ultraviolet electromagnetic energy.
- phase refers to the phase angle of an alternating- current (AC) radiofrequency (RF) voltage (sometimes referred to as an "RF signal” or “RF voltage”). In some cases, the term “phase” also refers to the phase angle difference between two RF voltages. Accordingly, the term “phased RF energy” refers to RF energy that comprises at least two component RF voltages, wherein each component RF voltage independently has a phase.
- AC alternating- current
- RF energy refers to the phase angle difference between two RF voltages.
- electrosurgical devices for applying phased RF energy to a treatment site such as biological tissue.
- the electrosurgical devices comprise an electrosurgical probe electrically coupled to a power source, as shown in Figure Ia.
- the electrosurgical device can be adapted, however, for "cordless" operation, and Figure Ib shows an electrosurgical device that combines an electrosurgical probe with a battery pack.
- the electrosurgical devices are adapted to promote electron conduction (i.e., electrical current) through biological tissue.
- RF devices disclosed herein generate different and adjustable electrical fields within the target site.
- the electrical fields are capable of manipulating electrons within the target site, thereby generating selective regions of elevated temperature.
- the electrosurgical probes disclosed herein employ a plurality of electrodes disposed on a treatment surface and adapted to be applied to a target biological tissue.
- the electrodes may be of any appropriate size or shape, and it will be appreciated that such will vary depending, for example, on the intended use.
- the treatment surface can be adapted to treat a variety of biological tissue surfaces. Accordingly, the treatment surface may be flat or curved.
- the electrodes may be uniformly disposed across the entire treatment surface, or may be concentrated in a particular section of the treatment surface. Typically, a regular pattern will be formed by the distribution of the electrodes on the treatment surface. The spacing between the electrode will depend, for example, on the probe geometry and the size of the electrodes.
- the spacing between the centers of any two adjacent electrodes will be between about 110% and about 1000% of the diameter of the electrodes, or, for non-circular electrodes the spacing will be between about 110% and about 1000% of the maximum width of the electrodes.
- the center-to-center distance between adjacent electrodes may be between about 0.001 mm and about 100 mm, or between about 0.01 mm and about 25 mm. In one embodiment, adjacent electrodes are spaced apart an average of about 0.01 mm to about 0.1 mm.
- Electrodes with circular cross-section are disposed in a regular pattern over a flat treatment surface.
- the electrodes may be either flush with the treatment surface, or the electrodes may protrude from the treatment surface.
- the electrosurgical probes comprise at least 3 electrodes, and may comprise any number of electrodes greater than 3, such as 4, 5, 6, 7, 8, 9, 10, 15, 20, 50, 100, or more.
- the probe in Figure 2a comprises 28 electrodes.
- the electrodes are electrically coupled to a power generator capable of providing a plurality of power outputs.
- the power generator may comprise a plurality of RF sources.
- the power generator may also comprise a single RF source, in which case the power generator further comprises appropriate circuitry to split the output of the RF source into a plurality of RF signals.
- the power generator further comprises a means for controlling the phase between any two of the power outputs. Such means for controlling will typically consist of phase shifting circuitry and the like, as will be appreciated by one of ordinary skill in the art.
- the phase angle between at least two RF sources in the electrosurgical devices disclosed herein is adjustable, but it will be appreciated that the configuration of the electrosurgical devices may vary.
- the power generator comprises two RF sources and phase shifting circuitry for adjusting the phase angle between the RF outputs of the two RF sources.
- the power generator comprises first, second, and third RF sources.
- the phases of each RF source are adjustable, such that the phase angles between the first and second, second and third, and first and third RF sources may be independently varied.
- the first RF source has fixed output, and the phases of the second and third RF sources are adjustable. This configuration also allows adjustment of the phase angle between any two of the RF sources.
- the first and second RF sources have fixed output, and the phase of the third RF source is adjustable.
- This configuration allows adjustment of the phase angle between the first and third, and second and third RF sources.
- adjustment of the phase angle between RF sources may be accomplished automatically via a feedback loop that responds to a measured electrical parameter (e.g., impendence at the target site, etc.), or may be accomplished manually via adjustment controls.
- the electrosurgical probe may be disposable, such that it is sterilized upon manufacture and is intended for a one-time use.
- the electrosurgical probe may be sterilizable (e.g., autoclavable) such that it is suitable for multiple uses and, in particular, use with multiple patients.
- an electrosurgical device comprising a means for applying light energy to the treatment site.
- means for applying light energy include coherent sources and incoherent sources, and may include sources such as lasers, ultraviolet lamps, infrared lamps, incandescent and fluorescent lamps, light emitting diodes, and the like.
- the means for applying light may be attached to the electrosurgical probe or may be separate from the electrosurgical probe.
- the electrosurgical device may include a means for lowering the temperature of the target site.
- Such means include electrical cooling devices such as a heat sink and delivery ports for delivering cooling liquids or gases to the target site and surrounding tissue.
- electrical contact cooling allows cooling of portions of the target site such as the epidermis, thereby minimizing pain and heat damage to surrounding (i.e., perilesional) skin.
- FIGs 2a-2d Various embodiments of the electrosurgical probes disclosed herein are shown in Figures 2a-2d.
- Figure 2a shows the treatment surface of electrosurgical probe 1 containing no cooling devices. Twenty-eight electrodes 2 are disposed on the treatment surface.
- Figure 2b shows the treatment surface of electrosurgical probe 3 containing pre-cooling device 4.
- Figure 2c shows the treatment surface of electrosurgical probe 5 containing post-cooling device 6.
- Figure 2d shows the treatment surface of electrosurgical probe 7 containing pre- cooling device 4 and light emitting optical source 8.
- the treatment portion (e.g., head or tip) of the electrosurgical probe of the device comprises a mechanism that allows all or a portion of the electrosurgical probe to mechanically vibrate during use. Such vibrations allow the treatment site to be massaged or otherwise soothed. This feature is especially preferred when the device is used to treat cellulite as described herein.
- the electrosurgical device may comprise a means for measuring an electrical characteristic, and optionally a feedback loop that allows the electrosurgical device to adjust the supplied electrical energy in response to the measured electrical characteristic.
- electrical characteristics include the electrical impedance and/or admittance of the target site, the current flowing between electrodes, the electrical potential between electrodes, output voltages and phases of the RF sources, and phase differentials between RF sources.
- Such measurements may be taken in real time as the electrosurgical probe is in close proximity to the target site, allowing the feedback loop to regulate the power supplied by the electrosurgical device to achieve the desired result.
- the electrosurgical device is adapted for treating the skin.
- the device generates an electric field which causes a current to flow through the stratum corneum, epidermis, and/or dermis, and comprises a means for reducing or increasing the power dissipated in the stratum corneum in response to a variation in a measured electrical characteristic.
- electrical characteristics may be selected from: a magnitude of the current; a time-integration of the current; a first time-derivative of the current; and a second time-derivative of the current. It will be appreciated that these electrical characteristics may be measured in biological tissues other than the stratum corneum when skin is not the target site.
- Characteristics of the electrodes may be independently measured and monitored by appropriate circuitry. Furthermore, the RF power sources may be adapted to modify the electric field generated by the electrodes so as to reduce the current through one or more of the electrodes, substantially independently of the current through any of the other electrodes.
- the electros ⁇ rgical devices described herein are useful in methods for delivering energy to a target site of a patient.
- Target sites suitable for the application of electrical energy using the devices disclosed herein include biological tissues such as skin, mucous membranes, organs, blood vessels, and the like.
- Energy is delivered to the target site via an electrosurgical probe, which is placed in close proximity to the target site.
- close proximity is meant that the probe is placed close enough to the target site to have a desired effect (e.g., tissue ablation, warming of the target site, etc.).
- the electrosurgical probe is placed in contact with the target site.
- an RP electrical potential is applied across two or more (typically three or four or more) electrodes present on the electrosurgical probe.
- This potential may, in some cases, cause a current to flow within the target site and between the electrodes.
- the potential causes an electric field to be applied to the target site.
- characteristics of the electric field e.g., intensity, direction, and the like
- the electrical field (F) generated by the electrosurgical probe is proportional to the phase between the RF sources and other electrical parameters of each RF source.
- This electrical field will vary according with the RF sources. These variations will attract and consequently move free electrons, thereby heating at least a portion of the target site. In another embodiment of the device these free electrons will tend to flow on the more heated paths in the treated area, which it is established using the light, flash or laser beam, as described herein.
- the target site is skin
- the electrosurgical device is placed in close proximity to the surface of the skin so as to generate an electric field that causes a current to flow through the stratum corneum, epidermis, and dermis.
- the induced electrical current may flow between electrodes, but may also have a significant component (e.g., 10%, 25%, 35%, 50%, 75% or more) in the direction that is perpendicular to the skin's surface.
- the devices disclosed herein are able to increase the temperature of the skin, and in some cases, ablate one or more layers of skin. For example, the devices are useful in fully or partially ablating the surface of the skin.
- the electrosurgical devices are also useful in partially or fully ablating one or more layers below the surface of the skin.
- the electrosurgical devices may be used to non- homogeneously increase the temperature of biological tissue as described herein.
- the electrosurgical devices may be used to increase the temperature of biological tissue within a narrow region relative to the size of the electrosurgical probe that is employed.
- the electrosurgical devices of the disclosure may be adapted to create one or more focal damage regions at the target site.
- Focal damage regions are isolated regions within the target site wherein tissue necrosis occurs. The sizes, locations, number, relative arrangement, and other factors of the focal damage regions are determined by the physical and electrical parameters of the electrosurgical devices, as well as operating conditions of the devices when in operation.
- focal damage regions may be created at any of the target sites described herein, the remaining discussion pertaining to this embodiment will primarily use human skin as an illustrative but non-limiting example.
- Figure 3 shows an illustrative example of a plurality of focal damage regions 9 created in skin tissue.
- the electrosurgical devices disclosed herein are able to create focal damage regions as a result of the adjustability of the phase angle between the RF sources.
- the RF sources are electrically coupled to electrodes on an electrosurgical probe; adjustment of the phase angle between RF sources causes variations in the electric field that is created in the vicinity of the electrodes. Such variations include areas of intensities and areas of weaknesses in the strength of the electric field, and may be used to manipulate electrons within the target site.
- appropriate modulation and adjustment of the phase between RF sources is used in the present disclosure to create heterogeneous electrical currents within the target site.
- Such electrical currents create regions of elevated temperature and are capable of creating tissue necrosis in the focal damage regions. Therefore, the temperature of the target site is proportional to the phase of the RF sources that are connected to the electrodes.
- the focal damage regions may be varied as desired and as appropriate for the intended application.
- the focal damage regions may be substantially columnar and perpendicular to the surface of the skin being treated.
- the columns may begin at or below the surface of the skin and extend to some depth below the surface. Therefore, the columns have proximal ends and distal ends, wherein the proximal end is either at the surface of the skin or nearest the surface of the skin, and the distal end is furthest from the surface of the skin.
- the proximal ends of the columns may be located about 0.1, 1, 2, 3, 4, 5, 10, 25, or 50 ⁇ m below the surface of the skin.
- the distal ends of the columns may be located about 1, 5, 10, 25, 50, 100, 1000, 2000, or 4000 ⁇ m below the surface of the skin.
- the width (i.e., diameter) of the columns may also vary, and may be between about 1 ⁇ m and about 7000 ⁇ m, or between about 10 ⁇ m and about 4000 ⁇ m.
- the columns may be at least 1, 10, 20, 30, 40, 50, 100, 150, 200, 250, 500, 800, 1000, 2000, or 5000 ⁇ m in width.
- the focal damage regions have widths that are in the range of about 50-100 ⁇ m, or about 50-70 ⁇ m.
- Tissue damage within the focal damage regions may be isolated within the upper layers of skin such as within the stratum corneum, or may be limited to skin cells located below the stratum corneum. Tissue damage may also extend across a plurality of layers of skin. Focal damage regions created by the electrosurgical devices disclosed herein may therefore extend through the stratum corneum and into the underlying layers of the epidermis and dermis. Focal damage regions may also be limited to the layers of the epidermis and dermis that are below the stratum corneum. Focal damage regions may be confined to the stratum corneum. Focal damage regions may also be confined to the stratum corneum and epidermis.
- Focal damage regions may also be confined to the stratum corneum, epidermis, and dermis. In general, the depth of the focal damage region may be selected by the operator of the device.
- the focal damage regions may have shapes other than columnar, such other shapes including pyramidal, egg-shaped, or spherical.
- the cross-section of the focal damage regions i.e., a cross-section taken parallel to the surface of the skin
- the focal damage regions is density - i.e., the number of focal damage regions that are created per unit area of tissue at the target site. Typical densities are at least about 1O 5 100, 200, 500, 1000, 2000, or 3000 cm "2 . In one embodiment, the density of focal damage regions is within the range of about 100-3000 cm "2 . Since the focal damage regions may be located entirely below the surface of the tissue at the target site, the density of focal damage regions can also refer to the number of regions in a unit area of a slice of the tissue at the target site. Most conveniently, such a slice of tissue will be parallel to the surface of the tissue at the target site. Again, without wishing to be bound by theory, the density of focal damage regions is a function of the number and density of electrodes, the phase relationship of the RF energy applied to the electrodes, operating conditions, and other factors that will appreciated by the skilled artisan.
- the focal damage regions can be created in a pattern in the target region.
- the orientation of focal damage regions at the target site is a function of the number and density of electrodes, the phase relationship of the RF energy applied to the electrodes, operating conditions, and other factors that will appreciated by the skilled artisan.
- the amount of energy required to create each focal damage region will vary with operating conditions, type of biological tissue, size of the damage region, and other factors. In one example, the amount of energy delivered to create each damage region is about 1 mJ*cm "3 .
- FIG. 4 shows a graphical representation of focal damage regions having proximal ends located below the surface of the tissue being treated by treatment probe 10.
- the region of tissue 11 between the proximal ends of focal damage regions 12 and the surface of the tissue is maintained at a cooler temperature compared with the tissue in the focal damage regions.
- Regions of tissue 13, located between focal damage regions 12, are also cooler than the tissue within the focal damage regions.
- Figure 5 shows a graphical representation of focal damage regions 12 that extend downward (i.e., deeper into the tissue) from the surface of the tissue.
- the electrosurgical probe may be translated (i.e., moved) parallel to the skin surface during the application of electrical energy to the skin. Such translation may occur with the probe either in contact with the skin or in close proximity to the skin. Translation of the probe allows for enlarged areas of treatment, improved heat dissipation, and other benefits as will be appreciated by the skilled artisan.
- the RF sources can also be programmed and controlled, using standard control circuitry, to apply RF energy to the electrodes in a time-dependent fashion, such that specific patterns of focal damage regions are created based on the rate and direction of translation of the electrosurgical probe.
- the pattern of focal damage regions can be predetermined using, for example, an image of the lesion acquired by digital imaging techniques and transferred to a control unit integrated with the electrosurgical device.
- the acne can be photographed and the electrosurgical device appropriately preprogrammed to ablate only lesions with specific lesions or pimples.
- Other examples include creating focal damage regions only on or near psoriatic lesions, or only in the region of a skin tattoo.
- the device is used to treat a patient with melasma having hyper-pigmented areas on part of the face.
- the electrosurgical device may be programmed to ablate the whole face with low depths of ablation.
- areas of the face characterized by greater hyper- pigmention may be treated with a higher density of focal damage regions while areas of the face that are characterized by less hyperpigmentation may be treated with a lower density of ablated regions.
- the tissue within the focal damage regions may be wholly or in part ablated or damaged. Regions of tissue between the focal damage regions will typically be heated due to dissipating heat from the electrodes, although such regions will not typically be ablated or permanently damaged.
- treatment of conditions of the skin using focal damage regions as described herein has the advantage of minimizing healing times due to minimized damage to the tissue surrounding the focal damage regions.
- electrical energy applied via the electrosurgical devices disclosed herein may be used to heat, but not destroy and/or damage, the target site.
- heat may be applied to effect collagen remodeling in a method for treating wrinkles.
- Phase controlled RF devices and methods as disclosed herein may be combined with other sources of energy.
- additional forms of energy allow synergistic effects for treatment of conditions such as skin disorders, skin aging and hair removal.
- focused ultrasound energy may cause micro-vibrations in susceptible living tissue.
- phase controlled RF and ultrasound energy are used to treat tissue. Examples of uses for the combination of phase controlled RF and ultrasound energy include the removal of hair and therapy of cellulite hair (e.g., hair removal or therapy that is safer and more efficient than existing methods).
- the methods disclosed herein may further comprise a pretreatment step such as: treatment with a topical anesthetic; cooling; and treatment with light energy.
- Topical anesthetics such as lidocain and the like may be applied as needed, such as 30-60 minutes prior to treatment with the electrosurgical device.
- Cooling of the target site as a pretreatment step may involve application of cooling agents such as gels, liquids, or gases. Examples include water and saline solutions, liquid nitrogen, carbon dioxide, air, and the like. Cooling may also involve electrical contact cooling. Typically, cooling of the target site is accomplished just prior to treatment with the electrosurgical probe, and has the effect of reducing pain and unwanted heat damage to the tissue surrounding the target site.
- Pretreatment with light energy may be accomplished using a light source integrated with the electrosurgical probe or with a separate light source, as described herein.
- Light energy is capable of effecting photothermolysis, and is useful in selectively heating regions of the target area. Accordingly, light energy can be used in conjunction with the electrosurgical devices. For example, regions of darker coloration such as hair and skin characterized by the presence of relatively large amounts of melanin (e.g., moles, hyperpigmented lesions, and the like) may be selectively heated, as such areas will absorb more light energy compared with regions with less pigmentation.
- Light energy may also be used to create preferred conduction pathways for the electrical currents that are produced by the electrosurgical probes described herein.
- Methods of treatment using light energy as well as the electrosurgical devices disclosed herein are particularly suitable for the treatment of hyperpigmented lesions, melasma, lentigines, wrinkles, and acne scars, as well as in hair removal, and the clearing of vascular lesions.
- post-treatment steps include treatment with a topical anesthetic as described above, and cooling of the target site and surrounding tissue as described above.
- the electrosurgical methods and devices disclosed herein may also be used in conjunction with an additional means for applying energy such as light and/or ultrasound energy to the target site.
- the electrosurgical probe may comprise an optical light source (e.g., lasers, incandescent lamps, gas-discharge lamps, and the like), a high-frequency ultrasound source, an infrared light source, an ultraviolet light source, or any combination thereof.
- Such additional means for applying energy may be electrically coupled to the same power source(s) that provide power to the electrodes of the electrosurgical probe, or may be electrically coupled to a separate power source.
- the methods and devices disclosed herein are useful in the field of electrosurgery in general, and more specifically in procedures that are suitable for treatment using RF energy.
- the methods and devices disclosed herein may be employed in procedures useful in the treatment of medical and aesthetic disorders and conditions affecting a patient's skin and subcutaneous tissue, including the following: skin resurfacing procedures; lessening the appearance of or removal of pigmentations; lessening the appearance, removing, or otherwise treating cellulite; therapy or removal of wrinkles, vascular lesions, scars and tattoos; hair removal and hair transplant procedures; treatment of skin cancer; skin rejuvenation; treatment of acne and psoriasis; debridment of chronic skin ulcers; and blepharoplasty procedures.
- the methods and devices disclosed herein are also useful in treating the signs of skin aging, including treatment of skin roughness, uneven pigmentation, wrinkles, and dilated capillaries.
- the devices disclosed herein are useful in methods for removing hair and for methods of hair transplantation.
- the phase-controlled RF can be used to create electric fields that specifically and selectively heat hair and hair follicles, particularly when such hair and hair follicles are located between electrodes such as is shown in Figure 6.
- treatment of hair can benefit by the use of light energy in addition to the electrosurgical probe, as disclosed herein and shown in Figure 7.
- Figure 8 further shows the effects of combining light energy with phased RF energy in treating skin and hair or hair follicles therein.
- heat from the light source accumulates in the melanin rich hair and hair follicle (Region 1), supplementing heat from RF energy. This enhances selectivity, thereby allowing selective warming and/or damage to hairs with decreased warming and/or damage to the surrounding, relatively melanin poor areas (Region 2).
- FIGs 9a, 9b, and 9c a phase controlled RF (PCRF) device with only four electrodes is shown. The electrodes are connected as two pairs, labeled RFl and RF2. Voltages Vl and V2 are applied to RFl and RF2, respectively, using two independent RF generators. Examples of Vl and V2 are shown in Figure 10. The voltage relation between Vl and V2 is described by equation (l).
- PCRF phase controlled RF
- V2 V' 0 sin(2 ⁇ ft+ ⁇ )
- Voi is the equivalent internal potential that is used to manipulate electrons within the target site.
- the phase between the RF generators is controlled by the RF Phase Control Unit, also shown in Figure 9a.
- Each RF generator is capable of delivering, for example, up to 500 watts to a typical load of 50 ohms at a frequency of 1 MHz, although it will be appreciated that such values may be greater or lesser as appropriate.
- Each RF generator has different inputs to control: (1) the power out of the unit; (2) the phase of the RF signal; (3) pulse duration; and (4) ON/OFF function.
- the device shown in Figure 9a may be implemented in a variety of ways, and it will be appreciated that the efficiency of the unit (i.e., Output Power as a ratio to Input Power) will vary accordingly.
- a Class D type RF generator is used, in one example, to provide a device with high efficiency ( ⁇ 90%).
- Figure 11 shows a typical Class D type RF generator.
- the RF Phase Control Unit is a low power unit that sets the phase of each RF generator unit.
- This unit implements a simple square wave generator where the phase of this square wave is set by a resistor-capacitor (RC) circuit or in a digital manner by setting the appropriate register of the square wave generator chip. Examples of this kind of semiconductor chip are chips named by the number 555 or 556 (dual 555) or any common phase-locked loop (PLL) chips.
- Another function of the RF Phase Control Unit is to control the power out of the RF generator units (RFGUs) 5 which is done by controlling the input voltage supplied to the RFGUs. The output power of an RFGU is proportional to the input voltage (see Figure 12). The input voltage is set on the AC power supply unit.
- the voltage supplied by the AC power supply unit is controlled by the microcontroller unit.
- functions such as ON/OFF, pulse duration, etc, are define on the microcontroller unit and transmitted to the Phase Control Unit (PCU), which in turn controls the RFGUs.
- PCU Phase Control Unit
- the device in Figure 9a also includes an Electrical Cooler Unit (ECU).
- this unit is a controlled power supply that generates a DC current to drive one or more electro-thermal TEK cooling device(s).
- the electrodes could be maintained at 5 0 C with an ambient temperature of 35 0 C. This may be accomplished by maintaining one side of the TEK at ambient temperature using, for example, the Fan unit shown in Figure 9a, which supplies ambient air flow to the electrodes.
- the input power to the Fan unit is supplied by the AC power supply unit.
- the AC power supply unit may supply, for example, a voltage that is proportional to the temperature of the electrodes.
- the AC power supply unit may supply all the needed voltages and currents for the various components of the device.
- the input voltage range for the AC power supply unit is preferably within the standard range, i.e., AC 95V-230V.
- the output voltages and currents will vary according to the needs of the components, and may include: +3.3 V at 5 A, +12V at 2A, and +0V to 60V at 8 A, with such voltages and currents being supplied to each component and/or each of multiple RF generators.
- the control interface unit allows control of the device by the user, such as a medical practitioner (for devices intended for hospital use) or an individual (for devices intended for personal use such as hair removal devices) and may include a computer 1585
- Such controls include, for example, power ON/OFF, control of menu setting, emergency power OFF push button, Power inlet, etc.
- FIG 9b another PCRF device is shown. This device is similar to the device shown in Figure 9a, except that a single RF generator is used, the output of which is supplied to multiple phase shift modules to generate different electrical phases at the electrodes. In instances where a relatively large number of different phases are desired or required, the approach exemplified by the device in Figure 9b may be relatively more economical as compared with the approach exemplified by the device in Figure 9a.
- Figure 9c another PCRF device (particularly suitable for cases in which low power is needed) is shown.
- a semiconductor chip with a custom package of VFBGA (very fine pitch ball grid array) type circuitry can be used to control the electrodes, RF generator, RF phase control unit, microcontroller unit, fan control unit and control interface unit.
- the system comprises a power supply unit, the custom semiconductor chip and relatively few buttons on a control unit for human interface.
- the control unit and power unit electrically attach to the semiconductor chip via a minimal number of wires, as appropriate.
- a focused ultrasound emitter is coupled with 2 pairs of electrodes (2 on each side, in the example shown) that are supplied with phase controlled RF energy.
- phase controlled RF energy e.g., RF energy supplied to a target tissue.
- both phased RF and ultrasound energies are emitted simultaneously.
- the applied energy and physical properties of the target tissue cause overheating of the hair shaft and a bulge to form in comparison to surrounding skin. This allows a selective pigment and/or hair removal system.
- Nylon fishing thread was used as a simulator (i.e., model) for hair.
- the nylon thread is similar to hair in that it has similar diameter, does not absorb water, and is non- conductive.
- Other simulators that were tried are cotton thread and a metallic needle.
- the tissue model used was chicken breast. When implanted in the model, nylon thread maintains the electrical property of being non-conductive. An infrared camera allowing a resolution of 100 ⁇ m was used to take real-time images of the model.
- An electrosurgical probe comprising 4 electrodes was used in phase-controlled mode.
- results were compared with results obtained from the same electrosurgical probe operating in a regular 2-electrode bipolar mode (i.e., only 2 electrodes were powered and the RF energy was not phase-controlled).
- the electrosurgical device did not show selective heating of the hair model.
- the nylon thread remained cooler than the surrounding tissue.
- the electrosurgical device showed selective heating of the hair model.
- the temperature of the nylon thread was found to be 20-40 0 C warmer than the surrounding tissue.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0706605A BRPI0706605B8 (en) | 2006-01-17 | 2007-01-17 | electrosurgical system employing phase-controlled radiofrequency energy |
EP07734828.2A EP2001385B1 (en) | 2006-01-17 | 2007-01-17 | Electrosurgical methods and devices employing phase-controlled radiofrequency energy |
CN200780009513.7A CN101505674B (en) | 2006-01-17 | 2007-01-17 | Electrosurgical methods and devices employing phase-controlled radiofrequency energy |
JP2008550878A JP2009527262A (en) | 2006-01-17 | 2007-01-17 | Electrosurgical method and apparatus using phase controlled radio frequency energy |
IL192810A IL192810A (en) | 2006-01-17 | 2008-07-14 | Electrosurgical system employing phase-controlled radiofrequency energy |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75928906P | 2006-01-17 | 2006-01-17 | |
US60/759,289 | 2006-01-17 | ||
US77416706P | 2006-02-17 | 2006-02-17 | |
US60/774,167 | 2006-02-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007099460A2 true WO2007099460A2 (en) | 2007-09-07 |
WO2007099460A3 WO2007099460A3 (en) | 2009-04-23 |
Family
ID=38459411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/001585 WO2007099460A2 (en) | 2006-01-17 | 2007-01-17 | Electrosurgical methods and devices employing phase-controlled radiofrequency energy |
Country Status (9)
Country | Link |
---|---|
US (4) | US8206381B2 (en) |
EP (2) | EP2532321A1 (en) |
JP (1) | JP2009527262A (en) |
KR (1) | KR20080107374A (en) |
CN (1) | CN101505674B (en) |
BR (1) | BRPI0706605B8 (en) |
IL (1) | IL192810A (en) |
RU (1) | RU2458653C2 (en) |
WO (1) | WO2007099460A2 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011505899A (en) * | 2007-12-05 | 2011-03-03 | シネロン メディカル リミテッド | Disposable electromagnetic energy applicator and method of using the same |
EP2560568A1 (en) * | 2010-04-19 | 2013-02-27 | The Procter & Gamble Company | Combined energy and topical composition application for regulating the condition of mammalian skin |
DE102012220665A1 (en) * | 2012-11-13 | 2014-05-15 | Olympus Winter & Ibe Gmbh | Electrosurgical instrument for use with high frequency-surgical device for ablation and coagulation of biological tissue, has electrodes electrically controlled, where electrode pair is formed between electrodes separated from each other |
US20150282857A1 (en) * | 2014-04-04 | 2015-10-08 | Covidien Lp | Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators |
US20150282861A1 (en) * | 2014-04-04 | 2015-10-08 | Covidien Lp | Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators |
US20150282860A1 (en) * | 2014-04-04 | 2015-10-08 | Covidien Lp | Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators |
EP2672911B1 (en) * | 2011-02-11 | 2017-09-06 | El.En. S.p.A. | Device for skin laser treatment |
WO2017183019A1 (en) | 2016-04-22 | 2017-10-26 | Syneron Medical Ltd. | Skin treatment apparatus and method |
WO2019049012A1 (en) * | 2017-09-07 | 2019-03-14 | Biosense Webster (Israel) Ltd. | Variable phase generation and detection for radio-frequency (rf) ablation |
US10342595B2 (en) | 2013-05-13 | 2019-07-09 | Creo Medical Limited | Dual-function plasma and non-ionising microwave coagulating electrosurgical instrument and electrosurgical apparatus incorporating the same |
EP2307095B1 (en) * | 2008-06-29 | 2020-06-03 | Venus Concept Ltd | An esthetic apparatus useful for increasing skin rejuvenation |
US11338134B2 (en) | 2019-07-24 | 2022-05-24 | Jeisys Medical Inc. | Skin treatment device using RF |
Families Citing this family (120)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060047281A1 (en) | 2004-09-01 | 2006-03-02 | Syneron Medical Ltd. | Method and system for invasive skin treatment |
US8535228B2 (en) | 2004-10-06 | 2013-09-17 | Guided Therapy Systems, Llc | Method and system for noninvasive face lifts and deep tissue tightening |
US10864385B2 (en) | 2004-09-24 | 2020-12-15 | Guided Therapy Systems, Llc | Rejuvenating skin by heating tissue for cosmetic treatment of the face and body |
US8444562B2 (en) | 2004-10-06 | 2013-05-21 | Guided Therapy Systems, Llc | System and method for treating muscle, tendon, ligament and cartilage tissue |
US9694212B2 (en) | 2004-10-06 | 2017-07-04 | Guided Therapy Systems, Llc | Method and system for ultrasound treatment of skin |
US8690778B2 (en) | 2004-10-06 | 2014-04-08 | Guided Therapy Systems, Llc | Energy-based tissue tightening |
US11883688B2 (en) | 2004-10-06 | 2024-01-30 | Guided Therapy Systems, Llc | Energy based fat reduction |
DK1855759T3 (en) | 2004-10-06 | 2017-06-06 | Guided Therapy Systems Llc | Tissue Ultrasound Treatment System |
US11235179B2 (en) | 2004-10-06 | 2022-02-01 | Guided Therapy Systems, Llc | Energy based skin gland treatment |
US8133180B2 (en) | 2004-10-06 | 2012-03-13 | Guided Therapy Systems, L.L.C. | Method and system for treating cellulite |
US9827449B2 (en) | 2004-10-06 | 2017-11-28 | Guided Therapy Systems, L.L.C. | Systems for treating skin laxity |
CA2583600A1 (en) | 2004-10-06 | 2006-04-20 | Guided Therapy Systems, L.L.C. | Method and system for noninvasive cosmetic enhancement |
US20060111744A1 (en) | 2004-10-13 | 2006-05-25 | Guided Therapy Systems, L.L.C. | Method and system for treatment of sweat glands |
US11207548B2 (en) | 2004-10-07 | 2021-12-28 | Guided Therapy Systems, L.L.C. | Ultrasound probe for treating skin laxity |
US11724133B2 (en) | 2004-10-07 | 2023-08-15 | Guided Therapy Systems, Llc | Ultrasound probe for treatment of skin |
US7856985B2 (en) | 2005-04-22 | 2010-12-28 | Cynosure, Inc. | Method of treatment body tissue using a non-uniform laser beam |
US9011473B2 (en) | 2005-09-07 | 2015-04-21 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US10548659B2 (en) | 2006-01-17 | 2020-02-04 | Ulthera, Inc. | High pressure pre-burst for improved fluid delivery |
US9486274B2 (en) | 2005-09-07 | 2016-11-08 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US7967763B2 (en) | 2005-09-07 | 2011-06-28 | Cabochon Aesthetics, Inc. | Method for treating subcutaneous tissues |
US8518069B2 (en) | 2005-09-07 | 2013-08-27 | Cabochon Aesthetics, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US9358033B2 (en) | 2005-09-07 | 2016-06-07 | Ulthera, Inc. | Fluid-jet dissection system and method for reducing the appearance of cellulite |
US7885793B2 (en) | 2007-05-22 | 2011-02-08 | International Business Machines Corporation | Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution |
US9248317B2 (en) | 2005-12-02 | 2016-02-02 | Ulthera, Inc. | Devices and methods for selectively lysing cells |
US9844682B2 (en) | 2006-01-17 | 2017-12-19 | Endymed Medical Ltd. | Skin treatment devices and methods |
US9827437B2 (en) | 2006-01-17 | 2017-11-28 | Endymed Medical Ltd | Skin treatment devices and methods |
US7586957B2 (en) | 2006-08-02 | 2009-09-08 | Cynosure, Inc | Picosecond laser apparatus and methods for its operation and use |
WO2008015681A1 (en) * | 2006-08-02 | 2008-02-07 | Syneron Medical Ltd. | Directed current for hair removal |
US8784425B2 (en) | 2007-02-28 | 2014-07-22 | Smith & Nephew, Inc. | Systems and methods for identifying landmarks on orthopedic implants |
EP2114263B1 (en) * | 2007-02-28 | 2019-02-20 | Smith & Nephew, Inc. | System for identifying a landmark |
WO2008105874A1 (en) * | 2007-02-28 | 2008-09-04 | Smith & Nephew, Inc. | Instrumented orthopaedic implant for identifying a landmark |
WO2008125962A2 (en) * | 2007-03-01 | 2008-10-23 | Endymed Medical Ltd. | Electrosurgical methods and devices employing semiconductor chips |
US9039697B2 (en) * | 2007-08-17 | 2015-05-26 | Endymed Medical Ltd. | Electrosurgical methods and devices employing inductive energy |
US8439940B2 (en) | 2010-12-22 | 2013-05-14 | Cabochon Aesthetics, Inc. | Dissection handpiece with aspiration means for reducing the appearance of cellulite |
CA2704740C (en) * | 2007-10-09 | 2016-05-17 | Transpharma Ltd. | Magnetic patch coupling |
DE202009017814U1 (en) | 2008-01-17 | 2010-07-01 | Syneron Medical Ltd. | Hair removal device for personal use |
KR20100115748A (en) | 2008-01-24 | 2010-10-28 | 시네론 메디컬 리미티드 | A device, apparatus, and method of adipose tissue treatment |
US9220514B2 (en) * | 2008-02-28 | 2015-12-29 | Smith & Nephew, Inc. | System and method for identifying a landmark |
EP2319447B1 (en) | 2008-03-31 | 2012-08-22 | Applied Medical Resources Corporation | Electrosurgical tool with jaws actuatable by a force regulation mechanism |
CN104545998B (en) | 2008-06-06 | 2020-07-14 | 奥赛拉公司 | System and method for cosmetic treatment and imaging |
US9314293B2 (en) | 2008-07-16 | 2016-04-19 | Syneron Medical Ltd | RF electrode for aesthetic and body shaping devices and method of using same |
US20100017750A1 (en) | 2008-07-16 | 2010-01-21 | Avner Rosenberg | User interface |
US8778003B2 (en) | 2008-09-21 | 2014-07-15 | Syneron Medical Ltd | Method and apparatus for personal skin treatment |
US8388615B2 (en) * | 2008-10-28 | 2013-03-05 | Smith & Nephew, Inc. | Electrosurgical device with controllable electric field profile |
US8357150B2 (en) | 2009-07-20 | 2013-01-22 | Syneron Medical Ltd. | Method and apparatus for fractional skin treatment |
KR20110101204A (en) | 2008-12-24 | 2011-09-15 | 가이디드 테라피 시스템스, 엘.엘.씨. | Methods and systems for fat reduction and/or cellulite treatment |
US8606366B2 (en) * | 2009-02-18 | 2013-12-10 | Syneron Medical Ltd. | Skin treatment apparatus for personal use and method for using same |
US20100211055A1 (en) * | 2009-02-18 | 2010-08-19 | Shimon Eckhouse | Method for body toning and an integrated data management system for the same |
EP2730313A1 (en) | 2009-02-25 | 2014-05-14 | Syneron Medical Ltd. | Electrical skin rejuvenation |
US8167280B2 (en) * | 2009-03-23 | 2012-05-01 | Cabochon Aesthetics, Inc. | Bubble generator having disposable bubble cartridges |
US9031637B2 (en) | 2009-04-27 | 2015-05-12 | Smith & Nephew, Inc. | Targeting an orthopaedic implant landmark |
US8945147B2 (en) | 2009-04-27 | 2015-02-03 | Smith & Nephew, Inc. | System and method for identifying a landmark |
US9402678B2 (en) | 2009-07-27 | 2016-08-02 | Novoxel Ltd. | Methods and devices for tissue ablation |
US11096708B2 (en) | 2009-08-07 | 2021-08-24 | Ulthera, Inc. | Devices and methods for performing subcutaneous surgery |
US9358064B2 (en) | 2009-08-07 | 2016-06-07 | Ulthera, Inc. | Handpiece and methods for performing subcutaneous surgery |
US8086734B2 (en) | 2009-08-26 | 2011-12-27 | International Business Machines Corporation | Method of autonomic representative selection in local area networks |
US20110112530A1 (en) * | 2009-11-06 | 2011-05-12 | Keller Craig A | Battery Powered Electrosurgery |
CN102781350B (en) | 2010-01-19 | 2016-09-14 | 得克萨斯大学体系董事会 | Produce the device of high-frequency percussion ripple and system and using method |
US20110196438A1 (en) * | 2010-02-10 | 2011-08-11 | Lukas Mnozil | Therapy device and method for treating underlying tissue using electrical and acoustic energies |
WO2011104702A1 (en) * | 2010-02-24 | 2011-09-01 | Syneron Medical Ltd. | A body contouring apparatus |
CN103096839A (en) | 2010-06-03 | 2013-05-08 | 史密夫和内修有限公司 | Orthopaedic implants |
US8974449B2 (en) * | 2010-07-16 | 2015-03-10 | Covidien Lp | Dual antenna assembly with user-controlled phase shifting |
EP2605718B1 (en) * | 2010-08-19 | 2015-03-04 | Syneron Medical Ltd. | Electromagnetic energy applicator for personal aesthetic skin treatment |
ES2664081T3 (en) | 2010-10-01 | 2018-04-18 | Applied Medical Resources Corporation | Electrosurgical system with a radio frequency amplifier and with means for adapting to the separation between electrodes |
US9005192B2 (en) * | 2010-11-08 | 2015-04-14 | Biosense Webster (Israel) Ltd. | Simultaneous ablation by multiple electrodes |
US9005193B2 (en) | 2010-11-08 | 2015-04-14 | Biosense Webster (Israel) Ltd. | Multichannel ablation with frequency differentiation |
CN101999931B (en) * | 2010-12-10 | 2012-11-14 | 上海导向医疗系统有限公司 | Cryoablation probe shell covered by expandable hydrogel and preparation method thereof |
WO2012103169A2 (en) | 2011-01-25 | 2012-08-02 | Smith & Nephew, Inc. | Targeting operation sites |
KR20140010374A (en) * | 2011-02-14 | 2014-01-24 | 시네론 메디컬 리미티드 | A method and apparatus for cosmetic skin treatment |
RU2013153116A (en) | 2011-05-06 | 2015-06-20 | Смит Энд Нефью, Инк. | TARGETING FOR SIGNIFICANT POINTS OF ORTHOPEDIC DEVICES |
JP6121406B2 (en) | 2011-06-16 | 2017-04-26 | スミス アンド ネフュー インコーポレイテッド | Surgical alignment using criteria |
US11865371B2 (en) | 2011-07-15 | 2024-01-09 | The Board of Regents of the University of Texas Syster | Apparatus for generating therapeutic shockwaves and applications of same |
KR20130056617A (en) * | 2011-11-22 | 2013-05-30 | 유앤아이 주식회사 | Rf electrod device for ablation of a needless body tissue |
KR101139940B1 (en) * | 2012-02-15 | 2012-05-07 | (주)인투케어 | Electrodes for electrical surgical procedures and device for surgical procedures including it |
KR102342629B1 (en) | 2012-04-18 | 2021-12-22 | 싸이노슈어, 엘엘씨 | Picosecond laser apparatus and methods for treating target tissues with same |
US9510802B2 (en) | 2012-09-21 | 2016-12-06 | Guided Therapy Systems, Llc | Reflective ultrasound technology for dermatological treatments |
CN104902836B (en) * | 2012-11-05 | 2017-08-08 | 毕达哥拉斯医疗有限公司 | Controlled tissue melts |
US9204921B2 (en) | 2012-12-13 | 2015-12-08 | Cook Medical Technologies Llc | RF energy controller and method for electrosurgical medical devices |
US9364277B2 (en) | 2012-12-13 | 2016-06-14 | Cook Medical Technologies Llc | RF energy controller and method for electrosurgical medical devices |
CN204637350U (en) | 2013-03-08 | 2015-09-16 | 奥赛拉公司 | Aesthstic imaging and processing system, multifocal processing system and perform the system of aesthetic procedure |
US20150005759A1 (en) * | 2013-03-14 | 2015-01-01 | Cynosure, Inc. | Current Delivery Systems, Apparatuses and Methods |
EP2968925B1 (en) | 2013-03-14 | 2020-02-19 | Cynosure, LLC | Electrosurgical systems |
US10285757B2 (en) | 2013-03-15 | 2019-05-14 | Cynosure, Llc | Picosecond optical radiation systems and methods of use |
WO2014145148A2 (en) | 2013-03-15 | 2014-09-18 | Ellman International, Inc. | Surgical instruments and systems with multimodes of treatments and electrosurgical operation |
EP3046620A1 (en) * | 2013-09-19 | 2016-07-27 | Koninklijke Philips N.V. | Treatment device for the skin using radio-frequency electric current |
PL2862533T3 (en) * | 2013-10-18 | 2019-12-31 | Erbe Elektromedizin Gmbh | Adapter element, HF surgery instrument, adapter set and system |
ES2875967T3 (en) | 2013-12-18 | 2021-11-11 | Novoxel Ltd | Devices for tissue vaporization |
SG11201608691YA (en) | 2014-04-18 | 2016-11-29 | Ulthera Inc | Band transducer ultrasound therapy |
US9675416B2 (en) * | 2014-04-28 | 2017-06-13 | Biosense Webster (Israel) Ltd. | Prevention of steam pops during ablation |
JP6573663B2 (en) | 2014-05-16 | 2019-09-11 | アプライド メディカル リソーシーズ コーポレイション | Electrosurgical system |
AU2015266619B2 (en) | 2014-05-30 | 2020-02-06 | Applied Medical Resources Corporation | Electrosurgical instrument for fusing and cutting tissue and an electrosurgical generator |
US10420602B2 (en) * | 2014-07-24 | 2019-09-24 | Koninklijke Philips N.V. | Treatment device using R.F. electrical current for heating a first inner region and a second inner region of skin |
CN111616796A (en) | 2014-09-15 | 2020-09-04 | 诺服塞尔有限公司 | Method and apparatus for thermal tissue vaporization and compression |
EP3236870B1 (en) | 2014-12-23 | 2019-11-06 | Applied Medical Resources Corporation | Bipolar electrosurgical sealer and divider |
USD748259S1 (en) | 2014-12-29 | 2016-01-26 | Applied Medical Resources Corporation | Electrosurgical instrument |
EP3095406B1 (en) * | 2015-05-19 | 2020-04-29 | Erbe Elektromedizin GmbH | Neutral electrode device for applying a hf current, electrosurgical system with corresponding neutral electrode device and method for producing a neutral electrode device |
AU2017208980B2 (en) | 2016-01-18 | 2022-03-31 | Ulthera, Inc. | Compact ultrasound device having annular ultrasound array peripherally electrically connected to flexible printed circuit board and method of assembly thereof |
TWI742110B (en) | 2016-07-21 | 2021-10-11 | 美商席利通公司 | Rapid pulse electrohydraulic (eh) shockwave generator apparatus with improved electrode lifetime and method of producing compressed acoustic wave using same |
KR102593310B1 (en) | 2016-08-16 | 2023-10-25 | 얼테라, 인크 | Ultrasound imaging system configured to reduce imaging misalignment, ultrasound imaging module, and method for reducing imaging misalignment |
US20170189703A1 (en) * | 2016-09-09 | 2017-07-06 | Shenzhen Peninsula Medical Co., Ltd. | Radio frequency treatment apparatus with self-adaptive treatment depth |
JP2020508112A (en) * | 2017-02-19 | 2020-03-19 | ソリトン, インコーポレイテッド | Selective laser-induced optical breakdown in biological media |
EP3372165A1 (en) * | 2017-03-07 | 2018-09-12 | Koninklijke Philips N.V. | Enhanced sampling using applied energy |
ES2883421T3 (en) * | 2017-07-28 | 2021-12-07 | Scandinavian Chemotech Ab | A device, eg, an electrodynamic enhanced pain control (DEEPC) device, for delivering electrical pulses to a desired body part of a mammal |
US11648047B2 (en) | 2017-10-06 | 2023-05-16 | Vive Scientific, Llc | System and method to treat obstructive sleep apnea |
CN117137607A (en) | 2018-02-07 | 2023-12-01 | 赛诺秀有限责任公司 | Method and apparatus for controlled RF processing and RF generator system |
WO2019161038A1 (en) * | 2018-02-16 | 2019-08-22 | Exploramed V Llc | Acne treatment system and methods |
US11944849B2 (en) | 2018-02-20 | 2024-04-02 | Ulthera, Inc. | Systems and methods for combined cosmetic treatment of cellulite with ultrasound |
KR102627248B1 (en) | 2018-02-26 | 2024-01-19 | 싸이노슈어, 엘엘씨 | Q-switched cavity dumping subnanosecond laser |
KR20210019020A (en) | 2018-06-11 | 2021-02-19 | 에이아이게인 뷰티 엘티디. | Artificial intelligence for improved skin tightening |
IT201800007740A1 (en) * | 2018-08-01 | 2020-02-01 | Oottat Srls | EQUIPMENT FOR REMOVING TATTOOS |
CA3111558A1 (en) | 2018-09-05 | 2020-03-12 | Applied Medical Resources Corporation | Electrosurgical generator control system |
US11317969B2 (en) * | 2018-10-22 | 2022-05-03 | Accure Acne Llc | Dosimetry determination process via measurement of skin surface temperature and associated methods |
US11696796B2 (en) | 2018-11-16 | 2023-07-11 | Applied Medical Resources Corporation | Electrosurgical system |
KR20220007884A (en) | 2019-05-09 | 2022-01-19 | 자이러스 에이씨엠아이, 인코포레이티드 디.비.에이. 올림푸스 써지컬 테크놀러지스 아메리카 | Electrosurgical systems and methods |
USD1005484S1 (en) | 2019-07-19 | 2023-11-21 | Cynosure, Llc | Handheld medical instrument and docking base |
USD971415S1 (en) | 2019-12-30 | 2022-11-29 | Cynosure, Llc | Flexible applicator |
KR102556846B1 (en) * | 2020-10-26 | 2023-07-18 | 주식회사 뉴아인 | Device that induces destroying cells on abnormally dividing cells and the driving method thereof |
KR102650606B1 (en) * | 2021-10-15 | 2024-03-21 | 가톨릭대학교 산학협력단 | Method and apparatus for supplying current for cancer treatment |
EP4279232A1 (en) | 2022-05-20 | 2023-11-22 | Koninklijke Philips N.V. | Electric shavers |
WO2024039836A1 (en) * | 2022-08-18 | 2024-02-22 | Lombardi Institute Of Dermatology, Pllc | Method, apparatus, and system for removal of papules |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1112720A1 (en) | 1999-12-29 | 2001-07-04 | Stockert, Rüdiger | Device for treating biological tissues with high frequency currents |
US20010008967A1 (en) | 1998-05-05 | 2001-07-19 | Sherman Marshall L. | RF ablation apparatus and method using unipolar and bipolar techniques |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1513057A (en) * | 1975-10-02 | 1978-06-07 | Slimmaster Beauty Equipment Lt | High frequency electronic epilation means |
US4750488A (en) * | 1986-05-19 | 1988-06-14 | Sonomed Technology, Inc. | Vibration apparatus preferably for endoscopic ultrasonic aspirator |
DE3604823C2 (en) * | 1986-02-15 | 1995-06-01 | Lindenmeier Heinz | High frequency generator with automatic power control for high frequency surgery |
US4974587A (en) * | 1988-12-22 | 1990-12-04 | Bsd Medical Corporation | Applicator array and positioning system for hyperthermia |
US5470332A (en) * | 1989-12-21 | 1995-11-28 | Thomas L. Mehl, Sr. | System for permanent removal of multiple hairs |
US5383917A (en) * | 1991-07-05 | 1995-01-24 | Jawahar M. Desai | Device and method for multi-phase radio-frequency ablation |
US5620481A (en) * | 1991-07-05 | 1997-04-15 | Desai; Jawahar M. | Device for multi-phase radio-frequency ablation |
US5542916A (en) | 1992-08-12 | 1996-08-06 | Vidamed, Inc. | Dual-channel RF power delivery system |
US5370645A (en) * | 1993-04-19 | 1994-12-06 | Valleylab Inc. | Electrosurgical processor and method of use |
US5817093A (en) * | 1993-07-22 | 1998-10-06 | Ethicon Endo-Surgery, Inc. | Impedance feedback monitor with query electrode for electrosurgical instrument |
WO1995010320A1 (en) * | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | Device for lengthening cardiac conduction pathways |
JPH09507645A (en) * | 1994-01-18 | 1997-08-05 | エンドバスキュラー・インコーポレイテッド | Vein ligation device and vein ligation method |
US5437664A (en) * | 1994-01-18 | 1995-08-01 | Endovascular, Inc. | Apparatus and method for venous ligation |
EP0768841B1 (en) * | 1994-06-27 | 2003-12-03 | Boston Scientific Limited | System for controlling tissue ablation using temperature sensors |
CA2194071C (en) * | 1994-06-27 | 2005-12-13 | Roger A. Stern | Non-linear control systems and methods for heating and ablating body tissue |
US6106524A (en) * | 1995-03-03 | 2000-08-22 | Neothermia Corporation | Methods and apparatus for therapeutic cauterization of predetermined volumes of biological tissue |
US5630426A (en) * | 1995-03-03 | 1997-05-20 | Neovision Corporation | Apparatus and method for characterization and treatment of tumors |
WO1996034567A1 (en) * | 1995-05-02 | 1996-11-07 | Heart Rhythm Technologies, Inc. | System for controlling the energy delivered to a patient for ablation |
US5660836A (en) * | 1995-05-05 | 1997-08-26 | Knowlton; Edward W. | Method and apparatus for controlled contraction of collagen tissue |
US5755753A (en) * | 1995-05-05 | 1998-05-26 | Thermage, Inc. | Method for controlled contraction of collagen tissue |
US6241753B1 (en) * | 1995-05-05 | 2001-06-05 | Thermage, Inc. | Method for scar collagen formation and contraction |
US5785708A (en) * | 1995-09-19 | 1998-07-28 | Lp Systems Corporation | Epilator probeholder |
US5931836A (en) * | 1996-07-29 | 1999-08-03 | Olympus Optical Co., Ltd. | Electrosurgery apparatus and medical apparatus combined with the same |
GB9708268D0 (en) | 1997-04-24 | 1997-06-18 | Gyrus Medical Ltd | An electrosurgical instrument |
WO1999017672A1 (en) * | 1997-10-06 | 1999-04-15 | Somnus Medical Technologies, Inc. | Electro-surgical instrument with a graphical user interface |
US6352536B1 (en) * | 2000-02-11 | 2002-03-05 | Sherwood Services Ag | Bipolar electrosurgical instrument for sealing vessels |
US6558378B2 (en) * | 1998-05-05 | 2003-05-06 | Cardiac Pacemakers, Inc. | RF ablation system and method having automatic temperature control |
US6171305B1 (en) | 1998-05-05 | 2001-01-09 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method having high output impedance drivers |
US6050994A (en) * | 1998-05-05 | 2000-04-18 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method using controllable duty cycle with alternate phasing |
US6042580A (en) * | 1998-05-05 | 2000-03-28 | Cardiac Pacemakers, Inc. | Electrode having composition-matched, common-lead thermocouple wire for providing multiple temperature-sensitive junctions |
US6045550A (en) * | 1998-05-05 | 2000-04-04 | Cardiac Peacemakers, Inc. | Electrode having non-joined thermocouple for providing multiple temperature-sensitive junctions |
US6123702A (en) * | 1998-09-10 | 2000-09-26 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6398779B1 (en) * | 1998-10-23 | 2002-06-04 | Sherwood Services Ag | Vessel sealing system |
US6148232A (en) * | 1998-11-09 | 2000-11-14 | Elecsys Ltd. | Transdermal drug delivery and analyte extraction |
US6423057B1 (en) * | 1999-01-25 | 2002-07-23 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method and apparatus for monitoring and controlling tissue temperature and lesion formation in radio-frequency ablation procedures |
JP4102031B2 (en) * | 1999-03-09 | 2008-06-18 | サーメイジ インコーポレイテッド | Apparatus and method for treating tissue |
US6958063B1 (en) * | 1999-04-22 | 2005-10-25 | Soring Gmbh Medizintechnik | Plasma generator for radio frequency surgery |
US6347251B1 (en) * | 1999-12-23 | 2002-02-12 | Tianquan Deng | Apparatus and method for microwave hyperthermia and acupuncture |
US8486065B2 (en) * | 2000-06-07 | 2013-07-16 | Wisconsin Alumni Research Foundation | Radio-frequency ablation system and method using multiple electrodes |
JP2002165889A (en) * | 2000-12-05 | 2002-06-11 | Iijima Seimitsu Kogyo Kk | Skin stimulation device |
US6620157B1 (en) * | 2000-12-28 | 2003-09-16 | Senorx, Inc. | High frequency power source |
US7166103B2 (en) * | 2001-10-01 | 2007-01-23 | Electrosurgery Associates, Llc | High efficiency electrosurgical ablator with electrode subjected to oscillatory or other repetitive motion |
US6889090B2 (en) * | 2001-11-20 | 2005-05-03 | Syneron Medical Ltd. | System and method for skin treatment using electrical current |
US6730078B2 (en) * | 2002-04-22 | 2004-05-04 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method using multi-frequency energy delivery |
ATE515285T1 (en) * | 2002-05-27 | 2011-07-15 | Celon Ag Medical Instruments | DEVICE FOR ELECTROSURGICAL DESCROPTION OF BODY TISSUE |
UA75342C2 (en) * | 2002-06-19 | 2006-04-17 | Borys Yevhenovych Paton | Technique for welding human and animal soft tissues |
US7341586B2 (en) * | 2002-08-21 | 2008-03-11 | Resect Medical, Inc. | Thermal coagulation of tissue during tissue resection |
JP3797302B2 (en) * | 2002-09-04 | 2006-07-19 | 株式会社日立製作所 | Medical manipulator system and operation method thereof |
JP3977217B2 (en) * | 2002-09-26 | 2007-09-19 | 積水化成品工業株式会社 | Electrode pad |
EP1653876A1 (en) | 2003-07-11 | 2006-05-10 | Reliant Technologies, Inc. | Method and apparatus for fractional photo therapy of skin |
JP4328884B2 (en) * | 2003-07-24 | 2009-09-09 | 関西電力株式会社 | Inverter device |
US20050283148A1 (en) * | 2004-06-17 | 2005-12-22 | Janssen William M | Ablation apparatus and system to limit nerve conduction |
US20060047281A1 (en) | 2004-09-01 | 2006-03-02 | Syneron Medical Ltd. | Method and system for invasive skin treatment |
US9039697B2 (en) * | 2007-08-17 | 2015-05-26 | Endymed Medical Ltd. | Electrosurgical methods and devices employing inductive energy |
-
2007
- 2007-01-17 WO PCT/IB2007/001585 patent/WO2007099460A2/en active Application Filing
- 2007-01-17 EP EP12167932A patent/EP2532321A1/en not_active Withdrawn
- 2007-01-17 KR KR1020087020161A patent/KR20080107374A/en not_active Application Discontinuation
- 2007-01-17 RU RU2008133567/14A patent/RU2458653C2/en active
- 2007-01-17 CN CN200780009513.7A patent/CN101505674B/en active Active
- 2007-01-17 US US11/654,914 patent/US8206381B2/en active Active
- 2007-01-17 EP EP07734828.2A patent/EP2001385B1/en active Active
- 2007-01-17 BR BRPI0706605A patent/BRPI0706605B8/en active IP Right Grant
- 2007-01-17 JP JP2008550878A patent/JP2009527262A/en active Pending
-
2008
- 2008-07-14 IL IL192810A patent/IL192810A/en active IP Right Grant
-
2012
- 2012-06-14 US US13/523,300 patent/US8512331B2/en active Active
-
2013
- 2013-02-27 US US13/779,237 patent/US8728071B2/en active Active
- 2013-04-18 US US13/865,658 patent/US20130231611A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010008967A1 (en) | 1998-05-05 | 2001-07-19 | Sherman Marshall L. | RF ablation apparatus and method using unipolar and bipolar techniques |
EP1112720A1 (en) | 1999-12-29 | 2001-07-04 | Stockert, Rüdiger | Device for treating biological tissues with high frequency currents |
Non-Patent Citations (1)
Title |
---|
See also references of EP2001385A4 |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011505899A (en) * | 2007-12-05 | 2011-03-03 | シネロン メディカル リミテッド | Disposable electromagnetic energy applicator and method of using the same |
EP2307095B1 (en) * | 2008-06-29 | 2020-06-03 | Venus Concept Ltd | An esthetic apparatus useful for increasing skin rejuvenation |
EP2560568B1 (en) * | 2010-04-19 | 2016-09-21 | Syneron Medical Ltd. | Combined energy and topical composition application for regulating the condition of mammalian skin |
EP2560568A1 (en) * | 2010-04-19 | 2013-02-27 | The Procter & Gamble Company | Combined energy and topical composition application for regulating the condition of mammalian skin |
US10149984B2 (en) | 2011-02-11 | 2018-12-11 | El.En. S.P.A. | Device and method for skin laser treatment |
EP2672911B1 (en) * | 2011-02-11 | 2017-09-06 | El.En. S.p.A. | Device for skin laser treatment |
DE102012220665A1 (en) * | 2012-11-13 | 2014-05-15 | Olympus Winter & Ibe Gmbh | Electrosurgical instrument for use with high frequency-surgical device for ablation and coagulation of biological tissue, has electrodes electrically controlled, where electrode pair is formed between electrodes separated from each other |
US10939948B2 (en) | 2013-05-13 | 2021-03-09 | Creo Medical Limited | Dual-function plasma and non-ionising microwave coagulating electrosurgical instrument and electrosurgical apparatus incorporating the same |
US10342595B2 (en) | 2013-05-13 | 2019-07-09 | Creo Medical Limited | Dual-function plasma and non-ionising microwave coagulating electrosurgical instrument and electrosurgical apparatus incorporating the same |
AU2015200376B2 (en) * | 2014-04-04 | 2016-11-17 | Covidien Lp | Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators |
EP2926752A3 (en) * | 2014-04-04 | 2015-11-04 | Covidien LP | Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators |
EP2926753A3 (en) * | 2014-04-04 | 2015-11-04 | Covidien LP | Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators |
US9949783B2 (en) | 2014-04-04 | 2018-04-24 | Covidien Lp | Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators |
US9974595B2 (en) | 2014-04-04 | 2018-05-22 | Covidien Lp | Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators |
US9987068B2 (en) | 2014-04-04 | 2018-06-05 | Covidien Lp | Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators |
US20150282857A1 (en) * | 2014-04-04 | 2015-10-08 | Covidien Lp | Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators |
US20150282860A1 (en) * | 2014-04-04 | 2015-10-08 | Covidien Lp | Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators |
US20150282861A1 (en) * | 2014-04-04 | 2015-10-08 | Covidien Lp | Systems and methods for optimizing emissions from simultaneous activation of electrosurgery generators |
US10933250B2 (en) | 2016-04-22 | 2021-03-02 | Syneron Medical Ltd. | Skin treatment apparatus and method |
WO2017183019A1 (en) | 2016-04-22 | 2017-10-26 | Syneron Medical Ltd. | Skin treatment apparatus and method |
WO2019049012A1 (en) * | 2017-09-07 | 2019-03-14 | Biosense Webster (Israel) Ltd. | Variable phase generation and detection for radio-frequency (rf) ablation |
US10945781B2 (en) | 2017-09-07 | 2021-03-16 | Biosense Webster (Israel) Ltd. | Variable phase generation and detection for radio-frequency (RF) ablation |
US11338134B2 (en) | 2019-07-24 | 2022-05-24 | Jeisys Medical Inc. | Skin treatment device using RF |
Also Published As
Publication number | Publication date |
---|---|
BRPI0706605B8 (en) | 2021-06-22 |
US8206381B2 (en) | 2012-06-26 |
CN101505674B (en) | 2014-03-05 |
BRPI0706605A2 (en) | 2011-03-29 |
RU2008133567A (en) | 2010-02-27 |
WO2007099460A3 (en) | 2009-04-23 |
RU2458653C2 (en) | 2012-08-20 |
US20130165928A1 (en) | 2013-06-27 |
JP2009527262A (en) | 2009-07-30 |
EP2532321A1 (en) | 2012-12-12 |
US20070191827A1 (en) | 2007-08-16 |
US8728071B2 (en) | 2014-05-20 |
IL192810A (en) | 2015-11-30 |
EP2001385A2 (en) | 2008-12-17 |
US20120265193A1 (en) | 2012-10-18 |
IL192810A0 (en) | 2009-08-03 |
BRPI0706605B1 (en) | 2019-06-04 |
EP2001385A4 (en) | 2009-12-09 |
KR20080107374A (en) | 2008-12-10 |
EP2001385B1 (en) | 2016-03-23 |
US8512331B2 (en) | 2013-08-20 |
US20130231611A1 (en) | 2013-09-05 |
CN101505674A (en) | 2009-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8206381B2 (en) | Electrosurgical methods and devices employing phase-controlled radiofrequency energy | |
US9039697B2 (en) | Electrosurgical methods and devices employing inductive energy | |
Alster et al. | Nonablative cutaneous remodeling using radiofrequency devices | |
US6766202B2 (en) | Systems and methods for intradermal collagen stimulation | |
US8323253B2 (en) | Method and device for tightening tissue using electromagnetic radiation | |
US20110218464A1 (en) | System, Device and Methods of Tissue Treatment for Achieving Tissue Specific Effects | |
US20080058783A1 (en) | Handheld Photocosmetic Device | |
US20080294150A1 (en) | Photoselective Islets In Skin And Other Tissues | |
US20070255355A1 (en) | Apparatus and method for skin treatment with compression and decompression | |
US20050055073A1 (en) | Facial tissue strengthening and tightening device and methods | |
KR20120068034A (en) | Method and device for minimally invasive skin and fat treatment | |
KR20120090007A (en) | Devices and methods for percutaneous energy delivery | |
US20090318916A1 (en) | Electrosurgical Methods and Devices Employing Semiconductor Chips | |
WO2008068749A1 (en) | Method and device for skin treatment using optical energy and rf | |
US20210370082A1 (en) | System and method for skin rejuvenation using impedance monitoring | |
KR20230133840A (en) | A cosmetic laser device that performs treatment by irradiating a variable pulse laser beam onto the human skin being treated. | |
Lloyd et al. | Laser-Tissue Interactions | |
Fritz et al. | Energy-based devices: Radiofrequency and high-intensity focused ultrasound | |
Wootten et al. | Radiofrequency microneedling in cosmetic dermatology | |
O’Connor et al. | Non-surgical skin tightening | |
Koch | Nonablative Facial Skin Rejuvenation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780009513.7 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 192810 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008550878 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2008133567 Country of ref document: RU Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007734828 Country of ref document: EP Ref document number: 1020087020161 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: PI0706605 Country of ref document: BR Kind code of ref document: A2 Effective date: 20080717 |